Bunce M, Procter J, Dunn P P, Day S, Ross J, Welsh K I
Transplantation Immunology, Nuffield Department of Surgery, Oxford Transplant Centre, Churchill Hospital, UK.
Tissue Antigens. 2000 Jan;55(1):31-6. doi: 10.1034/j.1399-0039.2000.550105.x.
We have identified a null HLA-A02 allele, HLA-A0232N, by using a combination of serology, flow cytometry, polymerase chain reaction using sequence-specific primers (PCR-SSP) and full-length sequencing. The null HLA-A2 allele was identified in an Asian individual originally typed by serology as an apparently homozygous HLA-A3, B51. Subsequent genotyping by PCR-SSP identified the genotype as HLA-A0201, 0301, B51, Cw1402. The serological type and lack of detectable HLA-A2 was confirmed using monoclonal antibody typing reagents. Flow cytometry studies failed to identify any cell surface HLA-A2 expression on the patient's peripheral blood lymphocytes. Genotyping using a PCR-SSP set designed to detect null alleles revealed the mutation had not been previously described. Full-length sequencing of the allele identified an allele which was subsequently named HLA-A0232N. This allele is identical to HLA-A0201 except for a novel point mutation (T for C) at position 493 which creates a premature stop codon. The sequencing enabled the development of a monospecific A0232N PCR-SSP reaction which was used to screen 973 DNA samples: no further examples of A0232N were identified.